RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R2032333 | ABT-346 | ATB-346 is a novel hydrogen sulphide-releasing derivative of naproxen with marke |
| R2032334 | ABT-751(E7010) | ABT-751(E 7010) is a novel bioavailable tubulin-binding and antimitotic sulfonam |
| R2032335 | AdipoRon | AdipoRon is an orally active adiponectin receptor (AdipoR) agonist, binding to A |
| R2032336 | ADL5859 | ADL5859 is a δ-opioid receptor agonist with Ki of 0.8 nM, selectivity against op |
| R2032337 | AG1024(Tyrphostin AG 1024) | AG1024 (Tyrphostin AG 1024) is a reversible, competitive and selective insulin-l |
| R2032338 | AM251 | AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 n |
| R2032339 | AM-281;AM281 | Potent, selective CB1 cannabinoid receptor antagonist/inverse agonist (Ki values |
| R2032340 | AMG837 | AMG 837 is a potent GPR40 agonist(EC50=13 nM) with a superior pharmacokinetic pr |
| R2032341 | AMG900 | AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor with IC50 |
| R2032342 | AT13148 | AT13148 is an orally active and ATP-competitive, multi-AGC kinase inhibitor with |
| R2032343 | AT-7867 | AT7867 is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA wi |
| R2032344 | Avelestat(AZD9668) | Alvelestat (AZD9668) is an orally bioavailable, affinity and selective inhibitor |
| R2032345 | AVP-AEW541;AEW541 | NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 0.15 μM, also inhibits I |
| R2032346 | AZ191 | AZ191 is a potent inhibitor that selectively inhibits DYRK1B with IC50 of 17 nM. |
| R2032347 | AZ20 | AZ20 is a potent and selective inhibitor of ATR with an IC50 of 5 nM, and has 8- |
| R2032348 | AZ3146 | AZ3146 is a reasonably potent and selective Mps1 inhibitor with IC50 of 35 nM fo |
| R2032349 | AZ960 | AZ960 is a potent and specific inhibitor of the JAK2 kinase with a Ki of 0.45 nM |
| R2032350 | Barasertib-HQPA;AZD2811;INH-34;AZD1152-HQPA | Barasertib-HQPA (AZD2811) is a highly selective Aurora B inhibitor with an IC50 |
| R2032351 | AZD1208 | AZD1208 is a novel, orally bioavailable, highly selective PIM kinases inhibitor. |
| R2032352 | AZD1283 | AZD1283 is a potent antagonist of the P2Y12 receptor with EC50 of 3.0 ug/kg/min, |
| R2032353 | Vistusertib (AZD2014) | Vistusertib (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 |
| R2032354 | AZD2932 | AZD2932 is a potent and multi-targeted kinase inhibitor VEGFR2, PDGFβ, Flt-3 and |
| R2032355 | AZD3514 | AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM a |
| R2032356 | AZD6482;AZD 6482 (KIN-193) | AZD 6482 (KIN-193) is a potent and selective p110β inhibitor with an IC50 of 0.6 |
| R2032357 | AZD7545 | AZD7545 is a potent, competitive, selective PDHK2 (pyruvate dehydrogenase kinase |
